Baotou Dongbao Bio-Tech Co Ltd (300239) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.19 Million ≈ $1.20 Million USD) by net assets (CN¥1.69 Billion ≈ $247.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Baotou Dongbao Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Baotou Dongbao Bio-Tech Co Ltd carry for a breakdown of total debt and financial obligations.

Baotou Dongbao Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Baotou Dongbao Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
XiAn Typical Industries Co Ltd SHG:600302	-0.029x
S.C. CHIMCOMPLEX S.A. RO:CRC	-0.008x
Shenzhen Huakong Seg Co Ltd SHE:000068	0.085x
Shandong Meichen Science & Technology Co Ltd SHE:300237	0.078x
CHTC Helon Co Ltd SHE:000677	-0.004x
Skandinaviska Enskilda Banken AB (publ) ST:SEB-C	1.189x
Zhejiang Aokang Shoes Co Ltd SHG:603001	0.002x
Capital Bancorp NASDAQ:CBNK	0.082x

Annual Cash Flow Conversion Efficiency for Baotou Dongbao Bio-Tech Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Baotou Dongbao Bio-Tech Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.74 Billion ≈ $254.53 Million	CN¥69.13 Million ≈ $10.12 Million	0.040x	-62.26%
2023-12-31	CN¥1.89 Billion ≈ $277.03 Million	CN¥199.39 Million ≈ $29.18 Million	0.105x	-5.32%
2022-12-31	CN¥1.76 Billion ≈ $256.94 Million	CN¥195.32 Million ≈ $28.58 Million	0.111x	+246.38%
2021-12-31	CN¥1.60 Billion ≈ $234.67 Million	CN¥51.50 Million ≈ $7.54 Million	0.032x	-49.22%
2020-12-31	CN¥998.18 Million ≈ $146.07 Million	CN¥63.13 Million ≈ $9.24 Million	0.063x	+250.67%
2019-12-31	CN¥991.86 Million ≈ $145.14 Million	CN¥-41.63 Million ≈ $-6.09 Million	-0.042x	-152.53%
2018-12-31	CN¥750.88 Million ≈ $109.88 Million	CN¥60.00 Million ≈ $8.78 Million	0.080x	+1970.83%
2017-12-31	CN¥729.75 Million ≈ $106.79 Million	CN¥-3.12 Million ≈ $-456.11K	-0.004x	-107.57%
2016-12-31	CN¥718.86 Million ≈ $105.19 Million	CN¥40.54 Million ≈ $5.93 Million	0.056x	-12.57%
2015-12-31	CN¥706.55 Million ≈ $103.39 Million	CN¥45.57 Million ≈ $6.67 Million	0.065x	+279.51%
2014-12-31	CN¥340.56 Million ≈ $49.83 Million	CN¥-12.24 Million ≈ $-1.79 Million	-0.036x	-239.04%
2013-12-31	CN¥351.47 Million ≈ $51.43 Million	CN¥9.08 Million ≈ $1.33 Million	0.026x	+53.46%
2012-12-31	CN¥324.03 Million ≈ $47.42 Million	CN¥5.46 Million ≈ $798.48K	0.017x	-79.42%
2011-12-31	CN¥295.99 Million ≈ $43.31 Million	CN¥24.22 Million ≈ $3.54 Million	0.082x	-15.71%
2010-12-31	CN¥122.44 Million ≈ $17.92 Million	CN¥11.88 Million ≈ $1.74 Million	0.097x	-29.35%
2009-12-31	CN¥100.65 Million ≈ $14.73 Million	CN¥13.83 Million ≈ $2.02 Million	0.137x	+422.49%
2008-12-31	CN¥97.87 Million ≈ $14.32 Million	CN¥-4.17 Million ≈ $-610.07K	-0.043x	--

About Baotou Dongbao Bio-Tech Co Ltd

SHE:300239 China Drug Manufacturers - Specialty & Generic

Market Cap

$482.96 Million

CN¥3.30 Billion CNY

Market Cap Rank

#12715 Global

#3970 in China

Share Price

CN¥5.56

Change (1 day)

+0.36%

52-Week Range

CN¥5.14 - CN¥6.63

All Time High

CN¥9.53